The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

Oxford, UK - 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the ...

The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the ...

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative ...

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) ...

Adenoviruses (Ad) are currently the most commonly used vectors in gene therapy clinical ... efficacy of the vector and causes toxic side effects. The 46 kDa coxsackie and adenovirus receptor ...

Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...

The adenoviridae family is divided into two genera: aviadenovirus, which causes disease in birds, and mastadenovirus, which infects a wide range of species, including humans. Human adenoviruses ...

SAN FRANCISCO—Kicking off J.P. Morgan week, Dyno Therapeutics announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed ...

It may be, she added, that weekly therapy sessions are simply not scalable to a broad population, and the field should explore light-touch alternatives, like single-session interventions and ...

Furthermore, the adenoviral helper plasmid pBHGlox(Δ)E1,3Cre (MiaoLingBio, China) underwent modification through the replacement of the fiber gene from adenovirus serotype ... Moreover, this viral ...